| Literature DB >> 33956241 |
Hibiki Umeda1, Satoru Kikuchi2, Shinji Kuroda1, Shuya Yano1, Takehiro Tanaka3, Kazuhiro Noma1, Masahiko Nishizaki1, Shunsuke Kagawa1, Yuzo Umeda1, Toshiyoshi Fujiwara1.
Abstract
BACKGROUND: Gastric yolk sac tumor (YST)-like carcinoma is extremely rare, and its prognosis is poor, because most patients have widespread metastases at the time of diagnosis. We report a case of gastric YST-like carcinoma with an adenocarcinoma component without metastases in which curative resection was performed. CASEEntities:
Keywords: Adenocarcinoma; Alpha-fetoprotein; Gastric yolk sac Tumor-like carcinoma
Year: 2021 PMID: 33956241 PMCID: PMC8102656 DOI: 10.1186/s40792-021-01199-3
Source DB: PubMed Journal: Surg Case Rep ISSN: 2198-7793
Fig. 1a Esophagogastroduodenoscopy shows an ulcerated tumor at the gastric cardia. b Narrow-band imaging of tumor shows irregular microvascular and microsurface patterns with wavy micro-vessels. c Esophagogastroduodenoscopy also shows an ulcer with exposed vessel at the mid-body of the stomach. d Computed tomography of the abdomen and pelvis shows no thickening of the stomach wall and no lymph node enlargement
Fig. 2a Resected specimens show Borrman type 3 tumor in the cardia (arrowheads). b–d Histological examination reveals an adenocarcinoma component and a yolk sac tumor (YST) component, with a reticular pattern (c) and Schiller–Duval bodies (d) are observed in YST component (hematoxylin and eosin staining)
Fig. 3Immunohistochemical staining of the tumor shows the yolk sac tumor (YST) component is positive for alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and p53. The adenocarcinoma (AC) component is positive for p53, but negative for AFP and CEA
Summary of gastric yolk sac tumor-like carcinomas in the literature
| Authors (year) | Age/Sex | Histology | Metastasis | Therapy | Prognosis |
|---|---|---|---|---|---|
| Garcia (1985) | 65/M | YST, CC, AC | Liver | None | Autopsy case |
| Motoyama (1985) | 72/F | YST, AC | LN | S | Alive (3 years) |
| Zamecnik (1993) | 88/M | YST | LN, Peritoneum | S | Died (4 weeks) |
| Suzuki (1999) | 56/M | YST, AC | LN | S, CT | Died (6 months) |
| Puglisi (1999) | 61/M | YST, AC | Peritoneum | Palliative S | Died (1 months) |
| Wang (2000) | 36/M | YST, AC | LN | CT | Died (6 months) |
| Napaki (2004) | 38/F | YST, AC | Liver | CT, S | Alive (32 months) |
| Kanai (2005) | 87/M | YST | None | S | Died (7 months) |
| Singh (2007) | 67/M | YST, AC | Liver, LN | S, CT | Died (2 months) |
| Tahara (2008) | 74/M | YST | Liver, Lung, LN | None | Died (6 days) |
| Kim (2009) | 61/M | YST | None | S | Alive (3 months) |
| Magni (2010) | 62/M | YST | LN | S, CT | Died (1 year) |
| (2011) | 74/M | YST, CC, AC | Liver, LN | S, RFA, CT | Alive (8 months) |
| Bihari (2013) | 50/M | YST, AC | Liver | None | NM |
| Yalaza (2017) | 68/F | YST, AC | LN | S, CT | Died (8 months) |
| Lakshmanan (2017) | 75/M | YST, AC, HC | None | S | Alive (30 months) |
| Qureshi (2018) | 52/M | YST, AC | LN | S, CT | Alive (16 months) |
| Mandelia (2018) | 3/M | YST | Liver, Peritoneum | CT, S | Alive (5 months) |
| Ibrahim (2019) | 86/F | YST | None | S | NM |
| Present case | 77/M | YST, AC | None | S | Alive (7 years) |
YST yolk sac tumor, AC adenocarcinoma, CC choriocarcinoma, HC hepatocellular carcinoma, LN lymph node, S surgery, CT chemotherapy, NM not mentioned